153 related articles for article (PubMed ID: 38430280)
1. Galectin-3 levels in children with cystic fibrosis.
Ademhan Tural D; Emiralioglu N; Akin S; Alboga D; Ozsezen B; Nayir Buyuksahin H; Guzelkas I; Kasikci M; Sunman B; Gungor I; Yalcin E; Dogru D; Kiper N; Demirel AH; Ozcelik U
Eur J Pediatr; 2024 May; 183(5):2333-2342. PubMed ID: 38430280
[TBL] [Abstract][Full Text] [Related]
2. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
4. Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function.
Seyfarth J; Sivagurunathan S; Ricken S; Weinreich G; Olbrich L; Taube C; Mayatepek E; Schramm D; Jacobsen M
J Cyst Fibros; 2019 Jan; 18(1):71-77. PubMed ID: 30389600
[TBL] [Abstract][Full Text] [Related]
5. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
8. SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.
Ben-Meir E; Perrem L; Shaw M; Ratjen F; Grasemann H
J Cyst Fibros; 2024 Mar; 23(2):288-292. PubMed ID: 38413298
[TBL] [Abstract][Full Text] [Related]
9. Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis.
Hovold G; Palmcrantz V; Kahn F; Egesten A; Påhlman LI
BMC Pulm Med; 2018 Jun; 18(1):104. PubMed ID: 29925362
[TBL] [Abstract][Full Text] [Related]
10. Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization.
AbdulWahab A; Allangawi M; Thomas M; Bettahi I; Sivaraman SK; Jerobin J; Chandra P; Ramanjaneya M; Abou-Samra AB
Cureus; 2021 Jun; 13(6):e15948. PubMed ID: 34221778
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
12. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
13. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
[TBL] [Abstract][Full Text] [Related]
14. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
[TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
16. Induced sputum nitrites correlate with FEV1 in children with cystic fibrosis.
Anil N; Singh M; Rajwanshi A; Vohra H
Acta Paediatr; 2010 May; 99(5):711-714. PubMed ID: 20096026
[TBL] [Abstract][Full Text] [Related]
17. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
Sagel SD; Wagner BD; Anthony MM; Emmett P; Zemanick ET
Am J Respir Crit Care Med; 2012 Nov; 186(9):857-65. PubMed ID: 22904182
[TBL] [Abstract][Full Text] [Related]
18. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
19. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases.
d'Alessandro M; De Vita E; Bergantini L; Mazzei MA; di Valvasone S; Bonizzoli M; Peris A; Sestini P; Bargagli E; Bennett D
Respir Physiol Neurobiol; 2020 Nov; 282():103546. PubMed ID: 32920057
[TBL] [Abstract][Full Text] [Related]
20. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
